Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Projected Compound Annual Growth Rate (CAGR) of the Meningococcal Vaccines Market from 2025 to 2034, and What Factors Influence It?
In the past few years, the size of the meningococcal vaccines market has seen a significant boost. Its growth, expected to increase from $3.89 billion in 2024 to $4.29 billion in 2025, will occur at a compound annual growth rate (CAGR) of 10.3%. Factors contributing to its growth during the historic period include occurrences of the disease, global travel patterns, the state of healthcare infrastructure, readiness for epidemics, and the extent of health insurance coverage.
The market size for meningococcal vaccines is projected to experience robust expansion in the upcoming years. The market is anticipated to escalate to $6.18 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%. Factors attributable to the growth during the forecast period include the emergence of new strains, intensifying globalization, expanding healthcare investments, health scheme initiations, and a transforming regulatory environment. Key trends during this period encompass custom-built vaccines, digital vaccination registry, gene alteration technologies, multi-valent vaccines, and the shift towards subscription-based vaccine models.
What Key Drivers Are Accelerating the Growth of the Market During the Forecast Period?
The meningococcal vaccine market is expected to witness growth, boosted by an anticipated rise in healthcare expenditure. Healthcare refers to a range of facilities such as a residential care institution, nursing facility, intermediate care facility catering to individuals with mental illnesses or mental retardation. The increased cost of new generations of vaccines, when compared to their older versions, has sparked significant debate about the cost effectiveness and benefits of these newer vaccines. The comprehensive socio-economic benefits of immunizations are becoming a pivotal focus in the research literature about vaccination value. For instance, an article by the American Medical Association in May 2022 cited that healthcare costs in the United States had surged by 9.7% to $4.1 trillion, equating to $12,530 per individual. This pattern of growth has substantially superseded that of 2019, which was 4.3%. Hence, the increase in healthcare expenditure is flushing the market with potential for meningococcal vaccine growth.
Explore Comprehensive Insights Into The Global Men’s Personal Care Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8013&type=smp
Who Are the Leading Players Fueling Growth in the Meningococcal Vaccines Market?
Major companies operating in the meningococcal vaccines market include:
• Pfizer Inc._x000D_
• GlaxoSmithKline plc_x000D_
• Sanofi Pasteur_x000D_
• Merck & Co. Inc._x000D_
• Serum Institute of India Pvt. Ltd._x000D_
What Are the Emerging Trends Shaping the Future of the Meningococcal Vaccines Market?
Key enterprises in the field of meningococcal vaccines are creating innovative vaccines aimed at preventing serogroups, aiming to enhance their market profitability. These vaccines serve as a proactive tactic to guard individuals against infections triggered by specific serogroups of Neisseria meningitidis bacteria. To illustrate, the US pharmaceutical giant, Pfizer Inc, obtained FDA approval for their vaccine, PENBRAYA, in October 2023. With its wide-ranging serogroup protection, PENBRAYA stands as the most wide-reaching meningococcal vaccine sanctioned by U.S authorities, providing defense against A, B, C, W, and Y groups. The FDA sanction was built on the solid dataset produced from Phase 2 and 3 trials, which showed non-inferior immunogenicity to Trumenba and Menveo for all serogroups, alongside a satisfactory safety profile. Furthermore, Pfizer unveiled favorable results from a Phase 3 comparative trial in September 2022, benchmarking PENBRAYA against existing FDA-licensed meningococcal vaccines in terms of safety, tolerability, and immunogenicity.
Get Instant Access to the Global Men’s Personal Care Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
Which Key Segments of the Men’s Personal Care Market Are Poised for Growth and Innovation?
The meningococcal vaccines market covered in this report is segmented –
1) By Vaccine Type: Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine
2) By Serotype: Men Acwy, Men B/Bc, Men C
3) By Age Group: Infants, Children, Adolescents and Young Adults, Adults
4) By Distribution Channel:: Pharmacies, Community Clinics, Public Health Agencies, Other Channels
5) By End user: Hospitals, Research, Academic Institutes
Subsegments:
1) By Meningococcal Conjugate Vaccine: Quadrivalent Conjugate Vaccine (MenACWY), Bivalent Conjugate Vaccine
2) By Polysaccharide Vaccine: Meningococcal Polysaccharide Vaccine (MPSV4), Group C Polysaccharide Vaccine
3) By Subcapsular Vaccine: Meningococcal B Vaccine (MenB), Combination Subcapsular Vaccines
Which Regions Are Driving Growth in the Meningococcal Vaccines Market?
North America was the largest region in the meningococcal vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the meningococcal vaccines market report during the forecast period. The regions covered in the meningococcal vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Men’s Personal Care Market Defined Across Different Regions?
Meningococcal vaccinations are vaccines that protect against meningococcal meningitis, an infection with the bacterium Neisseria meningitides that leads to inflammation of the tissues that surround the brain and spinal cord.
Browse Through More Similar Reports By The Business Research Company:
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024
Pediatric Vaccine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
DTP Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
